Loading…

Design, Synthesis, and Biological Evaluation of New-Generation Taxoids

Novel second-generation taxoids with systematic modifications at the C2, C10, and C3′N positions were synthesized and their structure−activity relationships studied. A number of these taxoids exhibited exceptionally high potency against multidrug-resistant cell lines, and several taxoids exhibited v...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2008-06, Vol.51 (11), p.3203-3221
Main Authors: Ojima, Iwao, Chen, Jin, Sun, Liang, Borella, Christopher P, Wang, Tao, Miller, Michael L, Lin, Songnian, Geng, Xudong, Kuznetsova, Larisa, Qu, Chuanxing, Gallager, David, Zhao, Xianrui, Zanardi, Ilaria, Xia, Shujun, Horwitz, Susan B, Mallen-St. Clair, Jon, Guerriero, Jennifer L, Bar-Sagi, Dafna, Veith, Jean M, Pera, Paula, Bernacki, Ralph J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a471t-5605249c9da9e640723502fdb1449cb2f481d1a4ad5f8a3fdfcb8d23a06d5a7e3
cites cdi_FETCH-LOGICAL-a471t-5605249c9da9e640723502fdb1449cb2f481d1a4ad5f8a3fdfcb8d23a06d5a7e3
container_end_page 3221
container_issue 11
container_start_page 3203
container_title Journal of medicinal chemistry
container_volume 51
creator Ojima, Iwao
Chen, Jin
Sun, Liang
Borella, Christopher P
Wang, Tao
Miller, Michael L
Lin, Songnian
Geng, Xudong
Kuznetsova, Larisa
Qu, Chuanxing
Gallager, David
Zhao, Xianrui
Zanardi, Ilaria
Xia, Shujun
Horwitz, Susan B
Mallen-St. Clair, Jon
Guerriero, Jennifer L
Bar-Sagi, Dafna
Veith, Jean M
Pera, Paula
Bernacki, Ralph J
description Novel second-generation taxoids with systematic modifications at the C2, C10, and C3′N positions were synthesized and their structure−activity relationships studied. A number of these taxoids exhibited exceptionally high potency against multidrug-resistant cell lines, and several taxoids exhibited virtually no difference in potency against the drug-sensitive and drug-resistant cell lines. These exceptionally potent taxoids were termed “third-generation taxoids”. 19 (SB-T-1214), 14g (SB-T-121303), and 14i (SB-T-1213031) exhibited excellent activity against paclitaxel-resistant ovarian cancer cell lines with mutations in β-tubulin as well, wherein the drug resistance is mediated by the β-tubulin mutation. These taxoids were found to possess exceptional activity in promoting tubulin assembly, forming numerous very short microtubules similar to those formed by discodermolide. Taxoids 19 and 14g also showed excellent cytotoxicity against four pancreatic cancer cell lines, expressing three to four multidrug-resistant genes. Moreover, taxoid 19 exhibited excellent in vivo efficacy against highly drug-resistant CFPAC-1 pancreatic as well as DLD-1 human colon tumor xenografts in mice.
doi_str_mv 10.1021/jm800086e
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2734907</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71648479</sourcerecordid><originalsourceid>FETCH-LOGICAL-a471t-5605249c9da9e640723502fdb1449cb2f481d1a4ad5f8a3fdfcb8d23a06d5a7e3</originalsourceid><addsrcrecordid>eNptkF1rFDEUhoModvtx4R-QuVEQOjafk8xNwdZ2K6xa6Hodzk6SbdbZpCYz_fj3RnbZKngRTjjn4T2HB6E3BH8kmJKT1VphjFVjX6AJERTXXGH-Ek0wprSmDWV7aD_nVWEYoew12iOKN6K8Cbr8bLNfhuPq5ikMt-WfjysIpjrzsY9L30FfXdxDP8LgY6iiq77Zh3pqg02bzhweozf5EL1y0Gd7tK0H6Mflxfz8qp59n345_zSrgUsy1KLBgvK2aw20tuFYUiYwdWZBeOkuqOOKGAIcjHAKmDOuWyhDGeDGCJCWHaDTTe7duFhb09kwJOj1XfJrSE86gtf_ToK_1ct4r6lkvMWyBLzfBqT4a7R50GufO9v3EGwcs5ak4YrLtoAfNmCXYs7Jut0SgvUf63pnvbBv_77qmdxqLsC7LQC5KHUJQufzjqOYY9FKUrh6w_k82MfdHNJP3UgmhZ5f3-jZ1dczLhXV0-dc6LJexTGFIv8_B_4Gek2lcQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71648479</pqid></control><display><type>article</type><title>Design, Synthesis, and Biological Evaluation of New-Generation Taxoids</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Ojima, Iwao ; Chen, Jin ; Sun, Liang ; Borella, Christopher P ; Wang, Tao ; Miller, Michael L ; Lin, Songnian ; Geng, Xudong ; Kuznetsova, Larisa ; Qu, Chuanxing ; Gallager, David ; Zhao, Xianrui ; Zanardi, Ilaria ; Xia, Shujun ; Horwitz, Susan B ; Mallen-St. Clair, Jon ; Guerriero, Jennifer L ; Bar-Sagi, Dafna ; Veith, Jean M ; Pera, Paula ; Bernacki, Ralph J</creator><creatorcontrib>Ojima, Iwao ; Chen, Jin ; Sun, Liang ; Borella, Christopher P ; Wang, Tao ; Miller, Michael L ; Lin, Songnian ; Geng, Xudong ; Kuznetsova, Larisa ; Qu, Chuanxing ; Gallager, David ; Zhao, Xianrui ; Zanardi, Ilaria ; Xia, Shujun ; Horwitz, Susan B ; Mallen-St. Clair, Jon ; Guerriero, Jennifer L ; Bar-Sagi, Dafna ; Veith, Jean M ; Pera, Paula ; Bernacki, Ralph J</creatorcontrib><description>Novel second-generation taxoids with systematic modifications at the C2, C10, and C3′N positions were synthesized and their structure−activity relationships studied. A number of these taxoids exhibited exceptionally high potency against multidrug-resistant cell lines, and several taxoids exhibited virtually no difference in potency against the drug-sensitive and drug-resistant cell lines. These exceptionally potent taxoids were termed “third-generation taxoids”. 19 (SB-T-1214), 14g (SB-T-121303), and 14i (SB-T-1213031) exhibited excellent activity against paclitaxel-resistant ovarian cancer cell lines with mutations in β-tubulin as well, wherein the drug resistance is mediated by the β-tubulin mutation. These taxoids were found to possess exceptional activity in promoting tubulin assembly, forming numerous very short microtubules similar to those formed by discodermolide. Taxoids 19 and 14g also showed excellent cytotoxicity against four pancreatic cancer cell lines, expressing three to four multidrug-resistant genes. Moreover, taxoid 19 exhibited excellent in vivo efficacy against highly drug-resistant CFPAC-1 pancreatic as well as DLD-1 human colon tumor xenografts in mice.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm800086e</identifier><identifier>PMID: 18465846</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Animals ; Antineoplastic agents ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Biological and medical sciences ; Biopolymers ; Cell Line, Tumor ; Drug Design ; Drug Resistance, Neoplasm ; Drug Screening Assays, Antitumor ; Female ; General aspects ; Humans ; Male ; Medical sciences ; Mice ; Mice, Nude ; Neoplasm Transplantation ; Paclitaxel - pharmacology ; Pharmacology. Drug treatments ; Point Mutation ; Structure-Activity Relationship ; Taxoids - chemical synthesis ; Taxoids - chemistry ; Taxoids - pharmacology ; Transplantation, Heterologous ; Tubulin - chemistry ; Tubulin - genetics</subject><ispartof>Journal of medicinal chemistry, 2008-06, Vol.51 (11), p.3203-3221</ispartof><rights>Copyright © 2008 American Chemical Society</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a471t-5605249c9da9e640723502fdb1449cb2f481d1a4ad5f8a3fdfcb8d23a06d5a7e3</citedby><cites>FETCH-LOGICAL-a471t-5605249c9da9e640723502fdb1449cb2f481d1a4ad5f8a3fdfcb8d23a06d5a7e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20405971$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18465846$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ojima, Iwao</creatorcontrib><creatorcontrib>Chen, Jin</creatorcontrib><creatorcontrib>Sun, Liang</creatorcontrib><creatorcontrib>Borella, Christopher P</creatorcontrib><creatorcontrib>Wang, Tao</creatorcontrib><creatorcontrib>Miller, Michael L</creatorcontrib><creatorcontrib>Lin, Songnian</creatorcontrib><creatorcontrib>Geng, Xudong</creatorcontrib><creatorcontrib>Kuznetsova, Larisa</creatorcontrib><creatorcontrib>Qu, Chuanxing</creatorcontrib><creatorcontrib>Gallager, David</creatorcontrib><creatorcontrib>Zhao, Xianrui</creatorcontrib><creatorcontrib>Zanardi, Ilaria</creatorcontrib><creatorcontrib>Xia, Shujun</creatorcontrib><creatorcontrib>Horwitz, Susan B</creatorcontrib><creatorcontrib>Mallen-St. Clair, Jon</creatorcontrib><creatorcontrib>Guerriero, Jennifer L</creatorcontrib><creatorcontrib>Bar-Sagi, Dafna</creatorcontrib><creatorcontrib>Veith, Jean M</creatorcontrib><creatorcontrib>Pera, Paula</creatorcontrib><creatorcontrib>Bernacki, Ralph J</creatorcontrib><title>Design, Synthesis, and Biological Evaluation of New-Generation Taxoids</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Novel second-generation taxoids with systematic modifications at the C2, C10, and C3′N positions were synthesized and their structure−activity relationships studied. A number of these taxoids exhibited exceptionally high potency against multidrug-resistant cell lines, and several taxoids exhibited virtually no difference in potency against the drug-sensitive and drug-resistant cell lines. These exceptionally potent taxoids were termed “third-generation taxoids”. 19 (SB-T-1214), 14g (SB-T-121303), and 14i (SB-T-1213031) exhibited excellent activity against paclitaxel-resistant ovarian cancer cell lines with mutations in β-tubulin as well, wherein the drug resistance is mediated by the β-tubulin mutation. These taxoids were found to possess exceptional activity in promoting tubulin assembly, forming numerous very short microtubules similar to those formed by discodermolide. Taxoids 19 and 14g also showed excellent cytotoxicity against four pancreatic cancer cell lines, expressing three to four multidrug-resistant genes. Moreover, taxoid 19 exhibited excellent in vivo efficacy against highly drug-resistant CFPAC-1 pancreatic as well as DLD-1 human colon tumor xenografts in mice.</description><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Biopolymers</subject><subject>Cell Line, Tumor</subject><subject>Drug Design</subject><subject>Drug Resistance, Neoplasm</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Female</subject><subject>General aspects</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Neoplasm Transplantation</subject><subject>Paclitaxel - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Point Mutation</subject><subject>Structure-Activity Relationship</subject><subject>Taxoids - chemical synthesis</subject><subject>Taxoids - chemistry</subject><subject>Taxoids - pharmacology</subject><subject>Transplantation, Heterologous</subject><subject>Tubulin - chemistry</subject><subject>Tubulin - genetics</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNptkF1rFDEUhoModvtx4R-QuVEQOjafk8xNwdZ2K6xa6Hodzk6SbdbZpCYz_fj3RnbZKngRTjjn4T2HB6E3BH8kmJKT1VphjFVjX6AJERTXXGH-Ek0wprSmDWV7aD_nVWEYoew12iOKN6K8Cbr8bLNfhuPq5ikMt-WfjysIpjrzsY9L30FfXdxDP8LgY6iiq77Zh3pqg02bzhweozf5EL1y0Gd7tK0H6Mflxfz8qp59n345_zSrgUsy1KLBgvK2aw20tuFYUiYwdWZBeOkuqOOKGAIcjHAKmDOuWyhDGeDGCJCWHaDTTe7duFhb09kwJOj1XfJrSE86gtf_ToK_1ct4r6lkvMWyBLzfBqT4a7R50GufO9v3EGwcs5ak4YrLtoAfNmCXYs7Jut0SgvUf63pnvbBv_77qmdxqLsC7LQC5KHUJQufzjqOYY9FKUrh6w_k82MfdHNJP3UgmhZ5f3-jZ1dczLhXV0-dc6LJexTGFIv8_B_4Gek2lcQ</recordid><startdate>20080612</startdate><enddate>20080612</enddate><creator>Ojima, Iwao</creator><creator>Chen, Jin</creator><creator>Sun, Liang</creator><creator>Borella, Christopher P</creator><creator>Wang, Tao</creator><creator>Miller, Michael L</creator><creator>Lin, Songnian</creator><creator>Geng, Xudong</creator><creator>Kuznetsova, Larisa</creator><creator>Qu, Chuanxing</creator><creator>Gallager, David</creator><creator>Zhao, Xianrui</creator><creator>Zanardi, Ilaria</creator><creator>Xia, Shujun</creator><creator>Horwitz, Susan B</creator><creator>Mallen-St. Clair, Jon</creator><creator>Guerriero, Jennifer L</creator><creator>Bar-Sagi, Dafna</creator><creator>Veith, Jean M</creator><creator>Pera, Paula</creator><creator>Bernacki, Ralph J</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20080612</creationdate><title>Design, Synthesis, and Biological Evaluation of New-Generation Taxoids</title><author>Ojima, Iwao ; Chen, Jin ; Sun, Liang ; Borella, Christopher P ; Wang, Tao ; Miller, Michael L ; Lin, Songnian ; Geng, Xudong ; Kuznetsova, Larisa ; Qu, Chuanxing ; Gallager, David ; Zhao, Xianrui ; Zanardi, Ilaria ; Xia, Shujun ; Horwitz, Susan B ; Mallen-St. Clair, Jon ; Guerriero, Jennifer L ; Bar-Sagi, Dafna ; Veith, Jean M ; Pera, Paula ; Bernacki, Ralph J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a471t-5605249c9da9e640723502fdb1449cb2f481d1a4ad5f8a3fdfcb8d23a06d5a7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Biopolymers</topic><topic>Cell Line, Tumor</topic><topic>Drug Design</topic><topic>Drug Resistance, Neoplasm</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Female</topic><topic>General aspects</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Neoplasm Transplantation</topic><topic>Paclitaxel - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Point Mutation</topic><topic>Structure-Activity Relationship</topic><topic>Taxoids - chemical synthesis</topic><topic>Taxoids - chemistry</topic><topic>Taxoids - pharmacology</topic><topic>Transplantation, Heterologous</topic><topic>Tubulin - chemistry</topic><topic>Tubulin - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ojima, Iwao</creatorcontrib><creatorcontrib>Chen, Jin</creatorcontrib><creatorcontrib>Sun, Liang</creatorcontrib><creatorcontrib>Borella, Christopher P</creatorcontrib><creatorcontrib>Wang, Tao</creatorcontrib><creatorcontrib>Miller, Michael L</creatorcontrib><creatorcontrib>Lin, Songnian</creatorcontrib><creatorcontrib>Geng, Xudong</creatorcontrib><creatorcontrib>Kuznetsova, Larisa</creatorcontrib><creatorcontrib>Qu, Chuanxing</creatorcontrib><creatorcontrib>Gallager, David</creatorcontrib><creatorcontrib>Zhao, Xianrui</creatorcontrib><creatorcontrib>Zanardi, Ilaria</creatorcontrib><creatorcontrib>Xia, Shujun</creatorcontrib><creatorcontrib>Horwitz, Susan B</creatorcontrib><creatorcontrib>Mallen-St. Clair, Jon</creatorcontrib><creatorcontrib>Guerriero, Jennifer L</creatorcontrib><creatorcontrib>Bar-Sagi, Dafna</creatorcontrib><creatorcontrib>Veith, Jean M</creatorcontrib><creatorcontrib>Pera, Paula</creatorcontrib><creatorcontrib>Bernacki, Ralph J</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ojima, Iwao</au><au>Chen, Jin</au><au>Sun, Liang</au><au>Borella, Christopher P</au><au>Wang, Tao</au><au>Miller, Michael L</au><au>Lin, Songnian</au><au>Geng, Xudong</au><au>Kuznetsova, Larisa</au><au>Qu, Chuanxing</au><au>Gallager, David</au><au>Zhao, Xianrui</au><au>Zanardi, Ilaria</au><au>Xia, Shujun</au><au>Horwitz, Susan B</au><au>Mallen-St. Clair, Jon</au><au>Guerriero, Jennifer L</au><au>Bar-Sagi, Dafna</au><au>Veith, Jean M</au><au>Pera, Paula</au><au>Bernacki, Ralph J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design, Synthesis, and Biological Evaluation of New-Generation Taxoids</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2008-06-12</date><risdate>2008</risdate><volume>51</volume><issue>11</issue><spage>3203</spage><epage>3221</epage><pages>3203-3221</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Novel second-generation taxoids with systematic modifications at the C2, C10, and C3′N positions were synthesized and their structure−activity relationships studied. A number of these taxoids exhibited exceptionally high potency against multidrug-resistant cell lines, and several taxoids exhibited virtually no difference in potency against the drug-sensitive and drug-resistant cell lines. These exceptionally potent taxoids were termed “third-generation taxoids”. 19 (SB-T-1214), 14g (SB-T-121303), and 14i (SB-T-1213031) exhibited excellent activity against paclitaxel-resistant ovarian cancer cell lines with mutations in β-tubulin as well, wherein the drug resistance is mediated by the β-tubulin mutation. These taxoids were found to possess exceptional activity in promoting tubulin assembly, forming numerous very short microtubules similar to those formed by discodermolide. Taxoids 19 and 14g also showed excellent cytotoxicity against four pancreatic cancer cell lines, expressing three to four multidrug-resistant genes. Moreover, taxoid 19 exhibited excellent in vivo efficacy against highly drug-resistant CFPAC-1 pancreatic as well as DLD-1 human colon tumor xenografts in mice.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>18465846</pmid><doi>10.1021/jm800086e</doi><tpages>19</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2008-06, Vol.51 (11), p.3203-3221
issn 0022-2623
1520-4804
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2734907
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Animals
Antineoplastic agents
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Biological and medical sciences
Biopolymers
Cell Line, Tumor
Drug Design
Drug Resistance, Neoplasm
Drug Screening Assays, Antitumor
Female
General aspects
Humans
Male
Medical sciences
Mice
Mice, Nude
Neoplasm Transplantation
Paclitaxel - pharmacology
Pharmacology. Drug treatments
Point Mutation
Structure-Activity Relationship
Taxoids - chemical synthesis
Taxoids - chemistry
Taxoids - pharmacology
Transplantation, Heterologous
Tubulin - chemistry
Tubulin - genetics
title Design, Synthesis, and Biological Evaluation of New-Generation Taxoids
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T07%3A37%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design,%20Synthesis,%20and%20Biological%20Evaluation%20of%20New-Generation%20Taxoids&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Ojima,%20Iwao&rft.date=2008-06-12&rft.volume=51&rft.issue=11&rft.spage=3203&rft.epage=3221&rft.pages=3203-3221&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm800086e&rft_dat=%3Cproquest_pubme%3E71648479%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a471t-5605249c9da9e640723502fdb1449cb2f481d1a4ad5f8a3fdfcb8d23a06d5a7e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71648479&rft_id=info:pmid/18465846&rfr_iscdi=true